Un caso de poroqueratosis diseminada eruptiva en un paciente oncológico tratado con trastuzumab y exemestano: ¿fenómeno asociado al cáncer o inducido por fármacos?
Authors:
- 1 July 2018
- journal article
- letter
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (6) , 559-560
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Cutaneous adverse effects of targeted therapiesJournal of the American Academy of Dermatology, 2015
- Eruptive disseminated porokeratosis: A new classification systemJournal of the American Academy of Dermatology, 2014
- Disseminated superficial porokeratosisDermatology Online Journal, 2010
- Poroceratose superficial disseminada num doente com colangiocarcinoma: manifestação paraneoplásica?Anais Brasileiros de Dermatologia, 2010
- Development of Segmental Superficial Actinic Porokeratosis during Immunosuppressive Therapy for Pemphigus VulgarisActa Dermato-Venereologica, 2010
- Eruptive disseminated superficial porokeratosis with rapid resolution: a drug-induced phenomenon?Clinical and Experimental Dermatology, 2009
- Disseminated superficial porokeratosis developed by immunosuppression due to rheumatoid arthritis treatmentThe Journal of Dermatology, 2009